Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency

Journal of Experimental Medicine

Volumn 207, Issue 7, 2010, Pages 1541-1554

  Walter, Jolan E ^a   Rucci, Francesca ^a   Patrizi, Laura ^a   Recher, Mike ^a   Regenass, Stephan ^c   Paganini, Tiziana ^d   Keszei, Marton ^b   Pessach, Itai ^a   Lang, Philipp A ^e   Poliani, Pietro Luigi ^d   Giliani, Silvia ^d   Al Herz, Waleed ^f   Cowan, Morton J ^g   Puck, Jennifer M ^g   Bleesing, Jack ^h   Niehues, Tim ⁱ   Schuetz, Catharina ^j   Malech, Harry ^k   DeRavin, Suk See ^k   Facchetti, Fabio ^d   Gennery, Andrew R ^l   Andersson, Emma ^a   Kamani, Naynesh R ^m   Sekiguchi, JoAnn ⁿ   Alenezi, Hamid M ^f   Chinen, Javier ^o   Dbaibo, Ghassan ^p   ElGhazali, Gehad ^q   Fontana, Adriano ^c   Pasic, Srdjan ^r   Detre, Cynthia ^b   Terhorst, Cox ^b   Alt, Frederick W ^b   Notarangelo, Luigi D ^a   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF TORONTO   (Canada)

^f AL SABAH HOSPITAL   (Kuwait)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j UNIVERSITY HOSPITAL ULM   (Germany)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^l NEWCASTLE UNIVERSITY   (United Kingdom)

^m CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

^p AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^q Faculty of Medicine   (Saudi Arabia)

^r Mother and Child Health Institute Belgrade rs   (Serbia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B CELL ACTIVATING FACTOR; FICOLL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; RAG1 PROTEIN; TRINITROPHENYL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GENE MUTATION; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN SECRETING CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; OMENN SYNDROME; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECRETORY CELL; SEVERE COMBINED IMMUNODEFICIENCY; VDJ EXON; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; ANTIBODY-PRODUCING CELLS; AUTOANTIBODIES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL PROLIFERATION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNITY; IMMUNIZATION; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; SPLEEN;

EID: 77954408510     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091927     Document Type: Article

References (77)

1. Agenès, F., and A.A. Freitas. 1999. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J. Exp. Med. 189:319-330. doi:10.1084/jem.189.2.319
2. Alt, F.W., and D. Baltimore. 1982. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc. Natl. Acad. Sci. USA. 79:4118-4122. doi:10.1073/pnas.79.13.4118
3. Brenchley, J.M., D.A. Price, T.W. Schacker, T.E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371. doi:10.1038/nm1511
4. Cabatingan, M.S., M.R. Schmidt, R. Sen, and R.T. Woodland. 2002. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J. Immunol. 169:6795-6805.
5. Cambridge, G., M.J. Leandro, M. Teodorescu, J. Manson, A. Rahman, D.A. Isenberg, and J.C. Edwards. 2006. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum. 54:3612-3622. doi:10.1002/art.22211
6. Cao, W., L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D.B. Rosen, Y.H. Wang, J.L. Shaw, Q. Du, et al. 2009. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206:1603-1614. doi:10.1084/jem.20090547
7. Carey, J.B., C.S. Moffatt-Blue, L.C. Watson, A.L. Gavin, and A.J. Feeney. 2008. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp. Med. 205:2043-2052. doi:10.1084/jem.20080559
8. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 14:603-615. doi:10.1016/S1074-7613(01)00135-2
9. Carneiro-Sampaio, M., and A. Coutinho. 2007. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv. Immunol. 95:51-82. doi:10.1016/S0065-2776(07)95002-6 (Pubitemid 47380503)
10. Casellas, R., T.A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M.C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science. 291:1541-1544. doi:10.1126/science.1056600
11. Cassani, B., P.L. Poliani, V. Marrella, F. Schena, A.V. Sauer, M. Ravanini, D. Strina, C.E. Busse, S. Regenass, H. Wardemann, et al. 2010a. Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome. J. Exp. Med. 207:1525-1540.
12. Cassani, B., P.L. Poliani, D. Moratto, C. Sobacchi, V. Marrella, L. Imperatori, D. Vairo, A. Plebani, S. Giliani, P. Vezzoni, et al. 2010b. Defect of regulatory T cells in patients with Omenn syndrome. J. Allergy Clin. Immunol. 125:209-216. doi:10.1016/j.jaci.2009.10.023
13. Cavadini, P., W. Vermi, F. Facchetti, S. Fontana, S. Nagafuchi, E. Mazzolari, A. Sediva, V. Marrella, A. Villa, A. Fischer, et al. 2005. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J. Clin. Invest. 115:728-732.
14. Chevrier, S., C. Genton, A. Kallies, A. Karnowski, L.A. Otten, B. Malissen, M. Malissen, M. Botto, L.M. Corcoran, S.L. Nutt, and H. Acha-Orbea. 2009. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc. Natl. Acad. Sci. USA. 106:3895-3900. doi:10.1073/pnas.0809736106
15. Daitch, L.E., M.W. Moore, D.M. Persiani, J.M. Durdik, and E. Selsing. 1992. Transcription and recombination of the murine RS element. J. Immunol. 149:832-840.
16. Darce, J.R., B.K. Arendt, S.K. Chang, and D.F. Jelinek. 2007a. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 178:5612-5622.
17. Darce, J.R., B.K. Arendt, X. Wu, and D.F. Jelinek. 2007b. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179:7276-7286.
18. de Villartay, J.P., A. Lim, H. Al-Mousa, S. Dupont, J. Déchanet-Merville, E. Coumau-Gatbois, M.L. Gougeon, A. Lemainque, C. Eidenschenk, E. Jouanguy, et al. 2005. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J. Clin. Invest. 115:3291-3299. doi:10.1172/JCI25178
19. Durdik, J., M.W. Moore, and E. Selsing. 1984. Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes. Nature. 307:749-752. doi:10.1038/307749a0 (Pubitemid 14133949)
20. Ehl, S., K. Schwarz, A. Enders, U. Duffner, U. Pannicke, J. Kühr, F. Mascart, A. Schmitt-Graeff, C. Niemeyer, and P. Fisch. 2005. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J. Clin. Invest. 115:3140-3148. doi:10.1172/JCI25221
21. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008. doi:10.1084/jem.177.4.999 (Pubitemid 23097389)
22. Giblin, W., M. Chatterji, G. Westfield, T. Masud, B. Theisen, H.L. Cheng, J. DeVido, F.W. Alt, D.O. Ferguson, D.G. Schatz, and J. Sekiguchi. 2009. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood. 113:2965-2975. doi:10.1182/blood-2008-07- 165167
23. Groom, J., S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, P. Schneider, J. Tschopp, T.G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109:59-68.
24. Halverson, R., R.M. Torres, and R. Pelanda. 2004. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5:645-650. doi:10.1038/ni1076
25. Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225. doi:10.1084/jem.173.5.1213
26. Hayakawa, K., M. Asano, S.A. Shinton, M. Gui, D. Allman, C.L. Stewart, J. Silver, and R.R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science. 285:113-116. doi:10.1126/science.285.5424.113
27. He, B., X. Qiao, and A. Cerutti. 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173:4479-4491. (Pubitemid 39280678)
28. Hondowicz, B.D., S.T. Alexander, W.J. Quinn III, A.J. Pagán, M.H. Metzgar, M.P. Cancro, and J. Erikson. 2007. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation. Int. Immunol. 19:465-475. doi:10.1093/intimm/ dxm011
29. Hsu, B.L., S.M. Harless, R.C. Lindsley, D.M. Hilbert, and M.P. Cancro. 2002. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168:5993-5996.
30. Kang, C.Y., T.K. Brunck, T. Kieber-Emmons, J.E. Blalock, and H. Kohler. 1988. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science. 240:1034-1036. doi:10.1126/science.3368787
31. Khan, W.N., F.W. Alt, R.M. Gerstein, B.A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Müller, A.B. Kantor, L.A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity. 3:283-299. doi:10.1016/1074-7613(95)90114-0
32. Khiong, K., M. Murakami, C. Kitabayashi, N. Ueda, S. Sawa, A. Sakamoto, B.L. Kotzin, S.J. Rozzo, K. Ishihara, M. Verella-Garcia, et al. 2007. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J. Clin. Invest. 117:1270-1281. doi:10.1172/JCI30513
33. Lavie, F., C. Miceli-Richard, M. Ittah, J. Sellam, J.E. Gottenberg, and X. Mariette. 2007. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann. Rheum. Dis. 66:700-703. doi:10.1136/ard.2006.060772
34. Lesley, R., Y. Xu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.B. Shu, and J.G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 20:441-453. doi:10.1016/S1074-7613(04) 00079-2
35. Lindh, E., S.M. Lind, E. Lindmark, S. Hässler, J. Perheentupa, L. Peltonen, O. Winqvist, and M.C. Karlsson. 2008. AIRE regulates T-cell-independent B-cell responses through BAFF. Proc. Natl. Acad. Sci. USA. 105:18466-18471. doi:10.1073/pnas.0808205105
36. Liston, A., A. Enders, and O.M. Siggs. 2008. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat. Rev. Immunol. 8:545-558. doi:10.1038/nri2336
37. Mackay, F., S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J.L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697-1710. doi:10.1084/jem.190.11.1697
38. Marrella, V., P.L. Poliani, A. Casati, F. Rucci, L. Frascoli, M.L. Gougeon, B. Lemercier, M. Bosticardo, M. Ravanini, M. Battaglia, et al. 2007. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J. Clin. Invest. 117:1260-1269. doi:10.1172/JCI30928
39. Mayne, C.G., I.J. Amanna, F.E. Nashold, and C.E. Hayes. 2008. Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur. J. Immunol. 38:587-598. doi:10.1002/eji.200737817
40. Melchers, F. 2006. Anergic B cells caught in the act. Immunity. 25:864-867. doi:10.1016/j.immuni.2006.11.003
41. Merrell, K.T., R.J. Benschop, S.B. Gauld, K. Aviszus, D. Decote-Ricardo, L.J. Wysocki, and J.C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity. 25:953-962. doi:10.1016/j.immuni.2006.10.017
42. Meyer-Bahlburg, A., S.F. Andrews, K.O. Yu, S.A. Porcelli, and D.J. Rawlings. 2008. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 205:155-168. doi:10.1084/jem.20071088
43. Miller, J.P., J.E. Stadanlick, and M.P. Cancro. 2006. Space, selection, and surveillance: setting boundaries with BLyS. J. Immunol. 176:6405-6410.
44. Mohan, C., E. Alas, L. Morel, P. Yang, and E.K. Wakeland. 1998. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101:1362-1372. (Pubitemid 28145253)
45. Moisini, I., and A. Davidson. 2009. BAFF: a local and systemic target in autoimmune diseases. Clin. Exp. Immunol. 158:155-163. doi:10.1111/j.1365-2249. 2009.04007.x
46. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563. doi:10.1016/S0092-8674(00)00078-7
47. Negishi, I., N. Motoyama, K. Nakayama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang, A.C. Chan, and D.Y. Loh. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 376:435-438. doi:10.1038/376435a0
48. Nijnik, A., S. Dawson, T.L. Crockford, L. Woodbine, S. Visetnoi, S. Bennett, M. Jones, G.D. Turner, P.A. Jeggo, C.C. Goodnow, and R.J. Cornall. 2009. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J. Clin. Invest. 119:1696-1705. doi:10.1172/JCI32743
49. Ochs, H.D., S.D. Davis, E. Mickelson, K.G. Lerner, and R.J. Wedgwood. 1974. Combined immunodeficiency and reticuloendotheliosis with eosinophilia. J. Pediatr. 85:463-465. doi:10.1016/S0022-3476(74)80445-2
50. Oettinger, M.A., D.G. Schatz, C. Gorka, and D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 248:1517-1523. doi:10.1126/science.2360047 (Pubitemid 120031576)
51. Panigrahi, A.K., N.G. Goodman, R.A. Eisenberg, M.R. Rickels, A. Naji, and E.T. Luning Prak. 2008. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J. Exp. Med. 205:2985-2994. doi:10.1084/jem.20082053
52. Pessach, I., J. Walter, and L.D. Notarangelo. 2009. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr. Res. 65:3R-12R. doi:10.1203/PDR. 0b013e31819dbe1e
53. Pillai, S., A. Cariappa, and S.T. Moran. 2004. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 197:206-218. doi:10.1111/j.0105-2896.2003.097.x
54. Poliani, P.L., F. Facchetti, M. Ravanini, A.R. Gennery, A. Villa, C.M. Roifman, and L.D. Notarangelo. 2009. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood. 114:105-108. doi:10.1182/blood-2009-03-211029
55. Radic, M.Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165-1173. doi:10.1084/jem.177.4.1165
56. Reimold, A.M., N.N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E.M. Gravallese, D. Friend, M.J. Grusby, F. Alt, and L.H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 412:300-307. doi:10.1038/35085509
57. Retter, M.W., and D. Nemazee. 1998. Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188:1231-1238. doi:10.1084/jem.188.7.1231
58. Rucci, F., L.D. Notarangelo, A. Fazeli, L. Patrizi, T. Hickernell, T. Paganini, K.M. Coakley, C. Detre, M. Keszei, J.E. Walter, et al. 2010. Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome. Proc. Natl. Acad. Sci. USA. 107:3024-3029. doi:10.1073/pnas.0914865107
59. Schatz, D.G., M.A. Oettinger, and D. Baltimore. 1989. The V(D)J recombination activating gene, RAG-1. Cell. 59:1035-1048. doi:10.1016/0092- 8674(89)90760-5
60. Scheiffele, F., and I.J. Fuss. 2002. Induction of TNBS colitis in mice. Curr. Protoc. Immunol. Chapter 15:15: 19.
61. Schuetz, C., K. Huck, S. Gudowius, M. Megahed, O. Feyen, B. Hubner, D.T. Schneider, B. Manfras, U. Pannicke, R. Willemze, et al. 2008. An immunodeficiency disease with RAG mutations and granulomas. N. Engl. J. Med. 358:2030-2038. doi:10.1056/NEJMoa073966
62. Schwarz, K., G.H. Gauss, L. Ludwig, U. Pannicke, Z. Li, D. Lindner, W. Friedrich, R.A. Seger, T.E. Hansen-Hagge, S. Desiderio, et al. 1996. RAG mutations in human B cell-negative SCID. Science. 274:97-99. doi:10.1126/science.274.5284.97
63. Signorini, S., L. Imberti, S. Pirovano, A. Villa, F. Facchetti, M. Ungari, F. Bozzi, A. Albertini, A.G. Ugazio, P. Vezzoni, and L.D. Notarangelo. 1999. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood. 94:3468-3478.
64. Sobacchi, C., V. Marrella, F. Rucci, P. Vezzoni, and A. Villa. 2006. RAG-dependent primary immunodeficiencies. Hum. Mutat. 27:1174-1184. doi:10.1002/humu.20408
65. Stadanlick, J.E., and M.P. Cancro. 2008. BAFF and the plasticity of peripheral B cell tolerance. Curr. Opin. Immunol. 20:158-161. doi:10.1016/j.coi.2008.03.015
66. Thien, M., T.G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20:785-798. doi:10.1016/j.immuni.2004.05.010
67. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020. doi:10.1084/jem.177.4.1009 (Pubitemid 23097390)
68. Tsai, C.L., A.H. Drejer, and D.G. Schatz. 2002. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination. Genes Dev. 16:1934-1949. doi:10.1101/gad.984502
69. Tsitsikov, E.N., J.C. Gutierrez-Ramos, and R.S. Geha. 1997. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc. Natl. Acad. Sci. USA. 94:10844-10849. doi:10.1073/pnas.94.20.10844
70. Ueda, Y., D. Liao, K. Yang, A. Patel, and G. Kelsoe. 2007. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J. Immunol. 178:3593-3601. (Pubitemid 46417626)
71. Vela, J.L., D. Aït-Azzouzene, B.H. Duong, T. Ota, and D. Nemazee. 2008. Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity. 28:161-170. doi:10.1016/j.immuni.2007.12.011
72. Villa, A., S. Santagata, F. Bozzi, S. Giliani, A. Frattini, L. Imberti, L.B. Gatta, H.D. Ochs, K. Schwarz, L.D. Notarangelo, et al. 1998. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 93:885-896. doi:10.1016/S0092-8674(00)81448-8
73. Villa, A., C. Sobacchi, L.D. Notarangelo, F. Bozzi, M. Abinun, T.G. Abrahamsen, P.D. Arkwright, M. Baniyash, E.G. Brooks, M.E. Conley, et al. 2001. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 97:81-88. doi:10.1182/blood.V97.1.81
74. Wardemann, H., S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science. 301:1374-1377. doi:10.1126/science.1086907
75. Wardemann, H., J. Hammersen, and M.C. Nussenzweig. 2004. Human autoantibody silencing by immunoglobulin light chains. J. Exp. Med. 200:191-199. doi:10.1084/jem.20040818
76. Zekavat, G., S.Y. Rostami, A. Badkerhanian, R.F. Parsons, B. Koeberlein, M. Yu, C.D. Ward, T.S. Migone, L. Yu, G.S. Eisenbarth, et al. 2008. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J. Immunol. 181:8133-8144.
77. Zouali, M., and B.D. Stollar. 1986. A rapid ELISA for measurement of antibodies to nucleic acid antigens using UV-treated polystyrene microplates. J. Immunol. Methods. 90:105-110. doi:10.1016/0022-1759(86)90390-X